Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-25-000173

Director sold 400 shares at $505.86 ($202,344)

  • Director acquired 796 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Bhatia Sangeeta N. · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-05-01 Grant or award : show line 1 in the form 10b5-1 +796 5,231 D
2025-05-02 Sale : show line 2 in the form 10b5-1 −400 $505.86 $202,344 4,831 D
Open-market sales · 400 sh · avg $505.86 · $202,344
Loading xslF345X05/wk-form4_1746476052.xml…